HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.

Abstract

Recently, it was reported that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors increased bone mineral density (BMD) in mice. We studied the effect of HMG-CoA reductase inhibitors on BMD of type 2 diabetes mellitus by a retrospective review of medical records. Sixty-nine type 2 diabetic patients were included. The control group (n = 33… (More)

Topics

7 Figures and Tables

Slides referencing similar topics